Physician profile
Thomas A Haldis
NPI 1588681449
$36,554.67
in general payments reported to CMS, 2019-2025
15 companies · $4,469 in 2025
The $4,469 reported for 2025 was more than what 91% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,384 · 2020: $3,577 · 2021: $16K · 2022: $1,387 · 2023: $1,599 · 2024: $3,061 · 2025: $4,469.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,740 · Food and Beverage: $4,388.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,740.09 |
| Food and Beverage | $4,387.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $19,295.82 | 2019-2021 | |
| Medtronic, INC. | $5,141.22 | 2021-2025 | Corevalve Evolut R, Onyx Frontier, Chocolate Pta Balloon Catheter |
| Edwards Lifesciences Corporation | $3,638.73 | 2019-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve, Evoque |
| Abbott Laboratories | $3,415.43 | 2019-2025 | Perclose Prostyle, Mitraclip, Amplatzer Amulet |
| Pfizer INC. | $3,050.00 | 2020-2021 | |
| Medtronic Vascular, INC. | $880.50 | 2019-2020 | |
| Boston Scientific Corporation | $475.04 | 2019-2025 | Versacross Access Solution, Watchman Flx, Watchman |
| Biotronik INC. | $268.28 | 2019-2023 | Orsiro Mission |
| Shockwave Medical, INC | $221.69 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abiomed | $62.60 | 2022 | |
| Bard Peripheral Vascular, INC. | $56.61 | 2019 | |
| Penumbra, INC. | $33.12 | 2019 | |
| Philips North America LLC | $15.63 | 2019 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Haldis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.